Journal

Field notes from the clinical back office.

Practical guides on building, running, and moving compliant telehealth businesses. Case studies join this page as our customers go live.

Latest · Verticals · Aug 2026

How to start a peptide business in 2026: the compliant playbook

The clinical model that makes a peptide program lawful, the pharmacy bench that supplies it, what you can market today, and how to build for the bulks list.

Read the guide

ComplianceAug 2026

HIPAA and your marketing stack: pixels, analytics, and ads for telehealth brands

Where the Meta pixel and GA4 collide with health privacy law, which pages they can never run on, and how to build a funnel you can defend.

Read the guide

ComplianceAug 2026

Telehealth informed consent: what states actually require

The disclosures states enumerate, the four axes they differ on, and how to build consent as a versioned, state-aware flow rather than a checkbox.

Read the guide

Build vs BuyAug 2026

Do DTC telehealth brands need an EHR? EHR vs. clinical infrastructure

What an EHR is actually for, what a DTC program actually runs, and the four questions that decide which system of record you need.

Read the guide

OperationsAug 2026

Labs for telehealth programs: at-home kits vs. draw networks

How kits and draw sites compare on completion, panels, and cost — and how to build the lab loop so results actually gate care.

Read the guide

VerticalsAug 2026

The GLP-1 maintenance phase: what programs do when patients reach goal

The four clinician-directed maintenance patterns, how to price the tier, and why programs without one hand their best patients to competitors.

Read the guide

OperationsAug 2026

Refunds, cancellations, and chargebacks for telehealth subscriptions

A refund matrix that fits clinical products, the dispute-rate math that threatens merchant accounts, and the moves that keep you under the thresholds.

Read the guide

OperationsAug 2026

Patient support for telehealth programs: the tickets that actually happen

The real ticket mix, the clinical/non-clinical triage line only licensed staff may cross, and the notifications that prevent the biggest queues.

Read the guide

VerticalsAug 2026

Launching a sexual health telehealth program: the async-first playbook

The cardiac screening that matters, the state rules, engineered discretion, and the men’s-health bundle that follows.

Read the guide

Build vs BuyAug 2026

The telehealth tech stack in 2026: what you build vs. what you rent

Eight layers, a build/rent verdict for each, and where the engineering time actually goes.

Read the guide

ComplianceAug 2026

Can your pharmacy ship there? Non-resident pharmacy licensing for telehealth brands

Why a pharmacy needs a license in every state it ships into, why the map is never fully green, and how to route orders so none go where the pharmacy cannot serve.

Read the guide

OperationsAug 2026

Do cash-pay telehealth programs need NPIs, CPT codes, and superbills?

Which pieces of the insurance world still apply when you never file a claim — and why superbills are a revenue feature for cash-pay programs.

Read the guide

ComplianceAug 2026

LegitScript certification for telehealth: what it takes, how long, and why applications fail

What the reviewers check, a realistic six-to-twelve-week timeline, and the five reasons applications go back.

Read the guide

OperationsAug 2026

Inside a compounded GLP-1 order: from prescription to doorstep

Seven stages, four regulated parties, and the status your product should show the patient at each one.

Read the guide

OperationsAug 2026

From signed contract to first prescription: a realistic telehealth launch timeline

A week-by-week map of launching on infrastructure — what gates the first prescription and what only looks like it does.

Read the guide

GrowthAug 2026

Pricing a GLP-1 subscription patients actually keep

Why retention is decided by month three, the four pricing structures and how they retain, and the unit economics to model.

Read the guide

VerticalsAug 2026

Adding TRT and hormone therapy to a GLP-1 brand

Labs, synchronous visits for controlled substances, monitoring cadence — and how to add the second vertical without splitting your funnel.

Read the guide

Build vs BuyAug 2026

The best white-label telehealth platforms in 2026: an honest comparison

Nine vendors sorted by model and fit — done-for-you operators, enterprise networks, developer platforms, and API infrastructure — with our bias disclosed.

Read the guide

API & AgentsAug 2026

Where AI stops: clinical escalation and the human in the loop

What an agent can safely do in a telehealth program, where a licensed clinician must decide, and the escalation design that keeps both true.

Read the guide

ComplianceAug 2026

How to find a collaborating physician for a telehealth practice

When NPs and PAs need one, what the agreement must cover state by state, what it costs, and the three ways telehealth practices get one — including the one that scales.

Read the guide

OperationsAug 2026

503A vs 503B: choosing a compounding pharmacy for your GLP-1 and peptide program

What each kind of pharmacy can make and ship, how strong programs use both, and the vetting checklist to run before the first order.

Read the guide

ComplianceAug 2026

Asynchronous telehealth in 2026: what you can prescribe without a video visit

Where store-and-forward prescribing is allowed, which drug classes still need a live visit, and how to build an intake that holds up.

Read the guide

ComplianceAug 2026

Anti-kickback and fee-splitting rules for cash-pay telehealth marketing

Affiliates, creators, referral bonuses, and revenue shares: which laws still apply when no insurance is billed, and how to structure deals that hold up.

Read the guide

Build vs BuyAug 2026

Telehealth platform pricing in 2026: the four models and what they hide

Per-visit, platform-plus-usage, revenue share, and PMPM — how vendors charge, what the headline excludes, and how to model true cost at three volumes.

Read the guide

RegulatoryJul 2026

The FDA just voted on seven peptides. Here’s what actually changed.

Six of seven peptides — BPC-157, TB-500, KPV, MOTS-c, Semax, Epitalon — got favorable PCAC votes. What that does and doesn’t change for your program.

Read the guide

RegulatoryJul 2026

The DEA extended telemedicine prescribing again. Here’s the 2026 map.

Controlled-substance telehealth stays lawful through December 31, 2026 — and the permanent special-registration framework is visible in outline. What to rely on and what to build.

Read the guide

VerticalsJul 2026

Compounded GLP-1s in 2026: the operator’s map.

The shortage era ended, but the patient-specific pathway continues. What changed, what remains, and the disciplines — documentation, sourcing, claims — that keep programs strong.

Read the guide

VerticalsJul 2026

Everyone is searching for retatrutide. You can’t sell it. Here’s what to do instead.

A phase-3 molecule with product-level demand: why the gray market is a trap, and the compliant playbook for owning the searches until approval.

Read the guide

VerticalsJul 2026

How to add GLP-1 weight care to your med spa

What it actually takes to prescribe GLP-1s compliantly — clinician coverage, intake, labs, and the parts you should never build yourself.

Read the guide

ComplianceJul 2026

The 50-state telehealth compliance checklist

Licensing, telehealth modality rules, EPCS, and board filings — what "compliant in every state" really means, state by state.

Read the guide

OperationsJul 2026

How to switch telehealth infrastructure without losing patients

A playbook for migrating an operating telehealth business: parallel-running stacks, moving records, and cutting over safely.

Read the guide

Build vs BuyJul 2026

White-label telehealth, explained

Portals, marketplaces, and API infrastructure — the three models behind "your brand, our clinicians," and how to choose between them.

Read the guide

Build vs BuyJul 2026

What it really costs to launch a telehealth product

The build-vs-buy math: every cost center between you and your first patient, and where the budget actually goes.

Read the guide

VerticalsJul 2026

How to offer hormone therapy online

HRT and TRT are labs-heavy, monitoring-heavy, and partly controlled-substance territory. What a compliant program requires.

Read the guide

OperationsJul 2026

For Clinicians: taking your practice direct

Leaving the platforms to own your panel, your brand, and your economics — and what handles the back office when you do.

Read the guide

Get started

From first call to first patient, in weeks.

A 15-minute intro call, sandbox credentials the same day, go-live in 3–4 weeks — new launches and existing patient bases alike.

Get Started See the API